ZA924613B - Implant compositions containing a biologically active protein,peptide or polypeptide - Google Patents
Implant compositions containing a biologically active protein,peptide or polypeptideInfo
- Publication number
- ZA924613B ZA924613B ZA924613A ZA924613A ZA924613B ZA 924613 B ZA924613 B ZA 924613B ZA 924613 A ZA924613 A ZA 924613A ZA 924613 A ZA924613 A ZA 924613A ZA 924613 B ZA924613 B ZA 924613B
- Authority
- ZA
- South Africa
- Prior art keywords
- biologically active
- peptide
- polypeptide
- active protein
- compositions containing
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 6
- 102000004196 processed proteins & peptides Human genes 0.000 title abstract 4
- 229920001184 polypeptide Polymers 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 239000007943 implant Substances 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000036765 blood level Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/07—Stiffening bandages
- A61L15/10—Stiffening bandages containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Materials Engineering (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Prostheses (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US71989891A | 1991-06-24 | 1991-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA924613B true ZA924613B (en) | 1993-03-31 |
Family
ID=24891827
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA924613A ZA924613B (en) | 1991-06-24 | 1992-06-23 | Implant compositions containing a biologically active protein,peptide or polypeptide |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP0523330B1 (enEXAMPLES) |
| JP (1) | JP3597205B2 (enEXAMPLES) |
| KR (1) | KR100221031B1 (enEXAMPLES) |
| CN (1) | CN1050301C (enEXAMPLES) |
| AT (1) | ATE135565T1 (enEXAMPLES) |
| AU (1) | AU656200B2 (enEXAMPLES) |
| BR (1) | BR9202374A (enEXAMPLES) |
| CA (1) | CA2071757C (enEXAMPLES) |
| DE (1) | DE69209173T2 (enEXAMPLES) |
| DK (1) | DK0523330T3 (enEXAMPLES) |
| ES (1) | ES2087337T3 (enEXAMPLES) |
| GE (1) | GEP19970992B (enEXAMPLES) |
| GR (1) | GR3019457T3 (enEXAMPLES) |
| HU (1) | HU217547B (enEXAMPLES) |
| IE (1) | IE74398B1 (enEXAMPLES) |
| IL (1) | IL102287A (enEXAMPLES) |
| LV (1) | LV11816B (enEXAMPLES) |
| MD (1) | MD1394G2 (enEXAMPLES) |
| MX (1) | MX9203175A (enEXAMPLES) |
| RU (1) | RU2080119C1 (enEXAMPLES) |
| SG (1) | SG47955A1 (enEXAMPLES) |
| TW (1) | TW215058B (enEXAMPLES) |
| UA (1) | UA26137C2 (enEXAMPLES) |
| ZA (1) | ZA924613B (enEXAMPLES) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
| EP1104296B1 (en) * | 1998-07-20 | 2012-06-13 | Peptech Animal Health Pty Limited | Bioimplant formulation |
| US8052982B2 (en) | 1998-07-20 | 2011-11-08 | Peptech Animal Health Pty Limited | Bioimplant formulation comprising lecithin and stearin |
| JP2001058955A (ja) * | 1999-06-17 | 2001-03-06 | Inst Of Physical & Chemical Res | 生理活性ペプチド徐放性製剤 |
| MXPA02008261A (es) | 2000-02-24 | 2002-11-29 | Monsanto Technology Llc | Formulaciones inyectables no acuosas para liberacion prolongada de somatotorpina. |
| WO2002000261A2 (en) | 2000-06-26 | 2002-01-03 | Monsanto Technology Llc | Surfactant-containing formulations for extended release of somatotropin |
| US6664234B1 (en) | 2000-06-30 | 2003-12-16 | Monsanto Technology Llc | Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin |
| JP4931282B2 (ja) * | 2000-10-02 | 2012-05-16 | 日本ケミカルリサーチ株式会社 | 生理活性ペプチド含有粉末 |
| DE10161078A1 (de) * | 2001-12-12 | 2003-08-28 | Achim Goepferich | Matrizes zur Stabilisierung und kontrollierten Freisetzung von Problemarzneistoffen |
| SE526959C2 (sv) * | 2003-10-02 | 2005-11-29 | Tikomed Ab | Bioartificellt implantat innefattande en semipermeabel barriär samt förfarande för reducering av risken för bildning av bindrväv vid implantatet efter implantering genom att barriären förses med en permeabel beläggning av bioaktiv metall |
| JP2005145821A (ja) * | 2003-11-11 | 2005-06-09 | Kao Corp | 打錠製剤 |
| PE20121799A1 (es) | 2009-12-21 | 2013-01-02 | Ambrx Inc | Polipeptidos de somatotropina porcina modificados y sus usos |
| EP2516454A4 (en) | 2009-12-21 | 2013-05-22 | Ambrx Inc | MODIFIED BOVINE SOMATOTROPIN POLYPEPTIDES AND ITS USES |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4271113A (en) * | 1978-04-17 | 1981-06-02 | Alza Corporation | Process for forming a passageway in an osmotic device |
| CA1257199A (en) * | 1986-05-20 | 1989-07-11 | Paul Y. Wang | Preparation containing bioactive macromolecular substance for multi-months release in vivo |
| US4863736A (en) * | 1987-03-16 | 1989-09-05 | Monsanto Company | Somatotropin prolonged release |
| US4795644A (en) * | 1987-08-03 | 1989-01-03 | Merck & Co., Inc. | Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins |
| EP0542915A1 (en) * | 1990-08-09 | 1993-05-26 | Endocon, Inc. | Multiple drug delivery system |
-
1992
- 1992-04-29 EP EP92107278A patent/EP0523330B1/en not_active Expired - Lifetime
- 1992-04-29 AT AT92107278T patent/ATE135565T1/de not_active IP Right Cessation
- 1992-04-29 DK DK92107278.1T patent/DK0523330T3/da active
- 1992-04-29 ES ES92107278T patent/ES2087337T3/es not_active Expired - Lifetime
- 1992-04-29 DE DE69209173T patent/DE69209173T2/de not_active Expired - Fee Related
- 1992-04-29 SG SG1996005631A patent/SG47955A1/en unknown
- 1992-05-04 TW TW081103470A patent/TW215058B/zh active
- 1992-06-19 JP JP18465792A patent/JP3597205B2/ja not_active Expired - Fee Related
- 1992-06-22 CA CA002071757A patent/CA2071757C/en not_active Expired - Fee Related
- 1992-06-22 IL IL10228792A patent/IL102287A/xx not_active IP Right Cessation
- 1992-06-23 HU HU9202092A patent/HU217547B/hu not_active IP Right Cessation
- 1992-06-23 RU SU925052163A patent/RU2080119C1/ru not_active IP Right Cessation
- 1992-06-23 KR KR1019920010911A patent/KR100221031B1/ko not_active Expired - Fee Related
- 1992-06-23 MX MX9203175A patent/MX9203175A/es not_active IP Right Cessation
- 1992-06-23 BR BR929202374A patent/BR9202374A/pt not_active Application Discontinuation
- 1992-06-23 CN CN92105065A patent/CN1050301C/zh not_active Expired - Fee Related
- 1992-06-23 ZA ZA924613A patent/ZA924613B/xx unknown
- 1992-06-23 AU AU18470/92A patent/AU656200B2/en not_active Ceased
- 1992-07-01 IE IE922020A patent/IE74398B1/en not_active IP Right Cessation
-
1993
- 1993-06-15 UA UA93002879A patent/UA26137C2/uk unknown
- 1993-07-31 GE GEAP19931351A patent/GEP19970992B/en unknown
-
1994
- 1994-07-12 MD MD94-0370A patent/MD1394G2/ro unknown
-
1996
- 1996-03-29 GR GR950403216T patent/GR3019457T3/el unknown
-
1997
- 1997-03-05 LV LVP-97-37A patent/LV11816B/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ227787A (en) | Peptides and compositions having growth hormone regulatory effects | |
| EP0212474A3 (en) | Bone morphogenetic peptides | |
| FI101938B1 (fi) | Polypeptidijohdannaisia | |
| LV11816B (en) | Implant compositions containing a biologically active protein, peptide or polypeptide | |
| ZA941771B (en) | Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof | |
| GR3021708T3 (en) | Human vascular permeability factor | |
| GR3030382T3 (en) | Cytokine restraining agents. | |
| NZ512083A (en) | Methods of increasing lean tissue mass using OB protein compositions | |
| EP0162813A3 (en) | Pharmaceutical compositions containing a dipeptide | |
| NZ216832A (en) | Bovine growth hormone implant | |
| GR3032775T3 (en) | Modified protein and peptide pharmaceuticals | |
| EP0383837A4 (en) | Alveolar surfactant proteins | |
| GR3031927T3 (en) | Cysteine depleted il-6 muteins | |
| ATE225806T1 (de) | D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet | |
| ATE366310T1 (de) | Menschliches chondromodulin-i-protein | |
| ATE93527T1 (de) | Peptide und deren benutzung. | |
| EP0490383A3 (en) | Peptides of the hiv-gag protein, their preparation and use | |
| NZ220325A (en) | Implants containing peptide or protein medicament in permeable polymeric coating | |
| EP0723016A3 (en) | Leukocyte activation factor | |
| MX9604539A (es) | Aminoacidos modificados para la distribucion de farmaco. | |
| EP0446100A3 (en) | Method for the quantitative determination of the biologically active form of the human nerve growth factor in protein liquids |